Qualigen Therapeutics (QLGN) Earnings Date & Reports

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

QLGN is expected to report earnings to rise 45.00% to -14 cents per share on March 01

Qualigen Therapeutics QLGN Stock Earnings Reports

Q4'22

Est.

$-0.14

Q3'22

Beat

by $0.04

Q2'22

Beat

by $0.05

Q1'22

Beat

by $0.05

The last earnings report on November 15 showed earnings per share of -10 cents, beating the estimate of -14 cents. With 48.88K shares outstanding, the current market capitalization sits at 2.79M.

View a ticker or compare two or three

Compare

QLGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For QLGN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company which focused on developing therapeutics for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

5857 Owens Avenue

Phone

+1 760 452-8111

Employees

Web

https://www.qlgntx.com